Position in CCCC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$615,865
+$608,722 QoQ
Shares Held
131,877
+4755.6% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,721,264 across 329 Biotechnology names. CCCC ranks #165 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $615,865 | 131,877 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $7,143 | 2,716 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,187 | 2,716 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,029 | 2,716 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,883 | 2,716 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $143,412 | 89,633 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $360,054 | 100,015 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $545,199 | 95,649 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $418,669 | 90,621 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $14,632 | 1,791 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $10,119 | 1,791 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,331 | 1,791 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $11,129 | 4,047 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $210,656 | 67,088 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $379,381 | 64,302 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $561,569 | 64,033 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $452,792 | 60,052 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $987,357 | 40,699 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,232,487 | 38,276 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,706,552 | 38,195 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,307,939 | 34,565 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $380,294 | 10,281 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $284,652 | 8,592 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||